 |
Travel
Medicine on the Black Sea
Gary
Podolsky MD
Objectives:
- Introduce Travel
Medicine
- Discuss common
immunizations and anti-malarial medications
- Discuss some diseases
unique to the black sea
Introduction-
what is Travel Medicine
Travel
Medicine, by definition is the prevention and treatment of illnesses
associated with travelling, but this may be widely interpreted by
a variety of clinics. We will define travel medicine to involve
the health of travelers before, during and after their trip. Traditionally
clinicians have focused on the prevention of infectious illnesses,
mainly through giving advice and immunizations.
In
the last several years there has been an increase in the number
of choices available for travelers: different anti-malarial medications,
different brands of vaccines, and more is known about the nature
and distribution of illnesses.
One
famous Travel Medicine doctor ruefully observed, "Travellers
today may only be able to afford their vaccines but not their trip".
We must try to present the appropriate information to patients
without becoming to technical so that they may make informed decisions
about their own health keeping in mind the benefits, costs, and
adverse events.
One
must keep abreast of the latest information available and educate
all clients so that they may make an informed choice of what they
want since cost as well as need must be factored in. It should be
emphasized that many very cheap common sense habits and precautions
are perhaps even more important than relying on expensive immunizations
to keep travellers healthy.
This
talk will focus on common situations that occur in a travel clinic.
There are many ways of approaching certain problems and examples
are taken from our travel clinic but there are many other perspectives
as well.
Travel
Medicine Practices
Travel
clinics should be familiar with all of the common immunizations
for travel, including yellow fever (even if they themselves do not
administer yellow fever onsite they should know enough to be able
to inform patients).
Phone
Advice For Setting Up Appointments
Obviously
every person comes in with a different medical history and distinct
itinerary so that any advice suggested over the phone is for an
itinerary and is not personal medical
advice . Individuals needing specific advice must be assessed
in person. Some vaccines are very strongly recommended while others
are not. Some are even discouraged because we may feel there is
not enough time to receive protection from them. It is only when
our medical staff reviews a person individually that we can remark
on what is either required or recommended in the context of their
geographic destinations; activities planned or anticipated; and
medical health or allergy profile for each patient. We encourage
a discourse during our visits so that we can go over the benefits,
limits and price of each vaccine so that our clients may have informed
consent for everything they receive. At each visit we give a record
of all immunizations administered including time for each booster
date if required.
On-Line
resources for Travelers who wish to research their itinerary
Many
travelers may wish to look up their risk of diseases by country
themselves and this is now made easy by some very good websites.
Both
the Centre for Disease Control (CDC) http://www.cdc.gov/travel/index.htm
and World Health organization (WHO) www.who.int
are very good places to start as they contain very detailed
and frequently updated information and are often quoted as the source
of other recommendations. They are the most likely places to find
news of new outbreaks and news bulletins. Another well written website
for travellers is www.travmed.com
which also sells useful traveller supplies. They have an on-line
book , International Guide to Traveller's Health , which
is completely free from their site.
Health
Care for Travelers Abroad
With
the onset of the Internet and near universal access to the Internet
patients travelling abroad may contact us. Email and Internet are
not reliable 100% of the time and we never give advice to people
we cannot examine. To keep our active travellers healthy we recommend
they contact a reputable local physician recommended through their
Canadian (or other country's) Embassy. Alternatively the International
Society of Travel Medicine keeps a website of travel clinics at
www.istm.org where travellers
may find clinics.
We
are also a part of IAMAT the International Association for Assistance
to Travelers www.iamat.org .
This group is fee to join and will help travelers find physicians
abroad at standardized rates. Our clinic is similarly available
to see travellers coming to Canada who are also seeking medical
aid within our Healthcare system.
Travel
Visits
When
the patient is seen it helps them to fill out a standard form of
their demographics, and medical history as well as additional information
on their previous immunization record (if known) and nature and
duration of their travel.
Short
term travelers will be at less at risk of significant diseases while
long term expatriates will approximate more of the risk of a regular
native who lives there. North Americans are of course wealthier,
have access to better food and accommodations so that they may be
much less at risk of diseases. Some developing countries may also
under report disease.
General
statements regarding the prevalence of commonly acquired diseases
are available (see references) and these have gone into making recommendations
for each country. Various authorities do not always agree on the
same advice for identical situations, but in modern travel medicine
there is usually agreement. WHO and CDC guidelines are accessible
by everyone and currently available for everyone. In the early days
of Travel medicine this information was more privileged and updated
infrequently but is much easier to find today. Physicians with computers
can easily practice simple travel medicine by looking up country
recommendations and anti-malarial advice.
The
decision to give specific immunizations is based on the prevalence
of the disease and the likelihood of the traveller acquiring it.
Many vaccines have become more expensive so that the patient must
also agree to pay for them.
Traveller's
Diarrhea
This
is very common in travelers and may approach 50% in some trips.
Although not usually serious, cramping, diarrhea, pain and dehydration
may occur.
Taking
Pepto-Bismol 2 tablets four times daily will significantly decrease
symptoms.
We
do not recommend preventative antibiotics but people may take a
strong antibiotic like Ciprofloxacin to treat diarrhea if they get
it (500mg twice daily) and Imodium.
There
is one vaccine against E.coli but it only works 20% of the time.
Some
areas of the world are now resistant against Ciprofloxacin such
as Cambodia and Azithromycin is used here instead.
Diarrhea
in the returned traveller may represent simple traveller's diarrhea
or be from a parasite.
Cyclospora
a relatively new protozoa, is resistant to cipro but very sensitive
to Septra.
Giardia
may also be in the differential diagnosis.
Other
parasites are possible. Some travelers living long term in endemic
countries will periodically deworm themselves by taking mebendazole
100mg twice per day for 3 days. If clinical suspicion part of the
work up for post trip diarrhea may include stool analysis for ova
and parasites.
Common
Immunizations :
Tetanus
Diptheria (Td) should be up to date and given every 10
yrs. This is standard within Canada and also applies to travellers.
Recently
adult pertussis has been suggested to be added to the Td formulation.
In Manitoba an adult pertussis is added to the Td received at age
14 although no recommendations for use in travellers or those with
tetanus prone wounds have been made.
Polio
(IPV) This may also be combined with Td (Td-polio) or
given separately (IPV), and should be given every 10 yrs for travelers
travelling outside North America. In 2001 a polio outbreak occurred
in the Dominican Republic and Health Canada had recommended that
all travelers to the Dominican Republic consider polio boosters.
Recently there have been no further cases and at present the Western
Hemisphere is considered polio free. Childhood polio series are
still completed. Polio is recommended for travelers to India, Africa
and other areas that have still had cases. It is hoped that near
universal vaccination will decrease the amount of susceptible people
available thereby ending wild type polio transmission. Using a model
similar to the small pox eradication program polio may be likewise
gone. Immunizations for travelers should proceed until eradication
is certain.

Figure
5 Distribution of tetanus diptheria and polio
Hepatitis
A vaccine is also strongly recommended for most of the developing
world.
Hepatitis
A is acquired from contaminated food or water and can make people
very sick.
Hepatitis
A may infect up 0.3 % of travellers (per month) staying in endemic
areas regardless of the type of accommodation. Backpackers and those
who go off the beaten path have higher rates. Usually Hepatitis
A is self-limited even with jaundice and illness. Some individuals,
particularly over 40 years may die from it. The vaccine gives protection
for 12 months. A second dose, which must be given no sooner than
6 months, will boost this protection to at least 10-20 yrs and by
some research likely lifelong. This is the most cost effective travel
vaccine.
 
Figure
6 Distribution of Hep A an B
Hepatitis
B is a different virus also causing hepatitis, although
it is acquired through blood and body fluids. It is more common,
is easier to catch and kills more people than HIV.
Risk
factors for Hepatitis B include: contact with blood and other bodily
fluids, unclean needles, unprotected sex (although even condoms
do not reduce the risk to zero), IV drugs, and blood transfusions.
People who will be staying longer than 3 months in countries where
Hepatitis B is very high are also recommended to have this vaccine.
Those
going for very short periods 1-2 weeks and not exposed to the above
risk factors do not need Hepatitis B. They may still wish it for
cumulative risks from other sources.
Hepatitis
B should be given in 2 full doses one month apart with a booster
dose after 6 months. (0,1,and 6 months).
All
the different brands of Hepatitis A and B are equally effective.
Some people prefer the pre mixed vaccine of Twinrix but if they
use this brand they must receive 2 full doses to be adequately protected
against both Hep A and B. Twinrix should be given in 2 full doses
one month apart with a booster dose after 6 months. (0,1, and 6
months).
Typhoid
Typhoid
is a bacterial food borne illness and is suggested for travellers
going to higher risk countries such as Africa and India. It is not
usually recommended for resorts
and tourist vaccinations but may be considered for extended or off
the beaten path travels.
Two
types of vaccines are used:
Injectable Typhoid (Typherix or Typhim Vi), which is good for
3 years.
Oral typhoid (ty21a) is 4-vaccine capsules, which are taken on
days 0,2,4, and 6. Antibiotics and alcohol interfere with the
vaccine. This vaccine gives 5 years of coverage.

Figure
7 Distribution of Typhoid
Rabies
Rabies
causes 60,000 deaths worldwide, half of which are in India. Countries
completely free of rabies include: Australia, New Zealand, Japan,
Honk Kong, Singapore, Great Britain, and some Scandinavian countries.
The virus Rhabdoviridae Lyssavirus causes
rabies. All mammals are capable of transmitting the disease to other
animals or people. 99% of cases are from dogs.

Figure
8 Rabies Distributions in the World
Animal
commonly carrying rabies:
- Dogs: Major vector of
rabies especially in Asia, Latin America, and Africa.
- Foxes: Europe, Arctic,
and North America.
- Raccoons: Eastern USA.
- Skunks: Mid Western USA
and Western Canada
- Mongooses: Yellow mongoose
in Asia and Africa, Indian mongoose in Caribbean Island.
- Coyotes: Asia, Africa,
and North America.
- Bats: Vampire bats from
Northern Mexico to Argentina. Insectivorous bats in Northern America
and Europe. Man to man transmission is possible (3 cases) but
precautions for medical or paramedical personnel receiving routine
vaccination is not needed.
Infections
with rabies occur when the virus is first inoculated into the victim
and then absorbed into a susceptible cell where it multiplies. The
virus then enters nerve endings. The virus will migrate to the brain
and once the virus has entered the brain, rabies symptoms begin
to occur. Rabies is almost universally fatal afterwards. The term
rabies refers only to when the person has the fatal condition. The
average incubation time before the development of symptoms is 90
days, although is has occurred is as little as 7-10 days up to greater
than a year. Rarely, only a few days resulted in rabies and 1 case
took over 16 years to emerge. Children tend to develop symptoms
faster because bites are closer to the brain (the virus has less
distance to travel towards the brain), and is often more severe.
Symptoms of rabies in people are divided into 2 types - encephalitic
(furious) and paralytic (dumb). Early symptoms may be vague and
non-specific (fever, upset stomach). Local symptoms may occur at
the bite site (burning, numbness, tingling or itching).
Characteristics
of encephalitic (furious) rabies:
- Fluctuating consciousness
from agitation to depression, which will gradually progress to
coma.
- Phobic spasms - aerophobia
and hydrophobia, (the fear of water and air).
- Signs of autonomic dysfunction
like fixed dilated pupils, increased salivation, excessive sweating
and priapism. Rabies is 100% fatal although four people to date
have survived, but all with neurological damage.
PREVENTION
AND TREATMENT OF RABIES
Pre-exposure
vaccination means giving the rabies vaccine to people who
might be exposed to rabies. The vaccine is given in three
doses at days 0, 7, 28, (or 21) with a booster at 1 year and
every 5 years after. It eliminates the need for post exposure
immunoglobulin treatment after a rabid bite, which may not
even be available in certain countries. It also simplifies
post exposure treatment to only 2 vaccine doses after being
bitten.
People
who should be vaccinated include researchers working with
rabies, veterinarians, and remote travellers. Spelunkers may
also be at risk of rabies from bats. Children of long-term
travellers might also be at high risk of rabies when living
in developing countries. |
POST
BIT TREATMENT
Cleaning
the bite site is the most important step in preventing rabies.
This should be done as soon as possible, first by
flushing the wound with soap and water, followed by 70% alcohol,
or tincture of iodine. |
Rabies
exposure graded by type of contact - r ecommended
treatment
- Touching, feeding,
or licks, (animal) on intact skin - No treatment
necessary.
- Nibbling of uncovered
skin, minor scratches or abrasions without bleeding licks
on broken skin. - Give vaccine. Stop treatment
if animal observed to be healthy after 10 days in quarantine
or lab tests one on animal are negative
- Single
or multiple bites Or scratches. Contaminated mucous membrane
by saliva (Licks). Give vaccine and rabies immunoglobulin.
May stop treatment if rabies tests result comes up negative
for the animal.
|
After
a rabid bite the rabies vaccine is usually given on days 0, 3, 7,
21, and 28. The vaccine is given in the deltoid (or thigh in children).
It is not to be given in the gluteal muscle because there is poor
absorption of the vaccine when it is given in the gluteal area.
Sometimes
a double dose of the vaccine is given on day 0 if the patient is
immune deficient or had a very bad bite. If a person who had been
previously vaccinated within 5 years is bitten they only require
2 booster doses at days 0 and 3 but do not need rabies immunoglobulin.
Rabies
immunoglobulin is given to those people with severe bite(s) who
have no prior antibodies. (Antibodies will bind to the virus to
prevent it from entering nerve tissue and spreading to the brain.)
This
should be given as soon as possible after being bitten since rabies
has developed a few days after being bitten. People will begin to
produce their own antibodies 7-10 days after being vaccinated. The
immunoglobulin should be injected into the wound with a separate
syringe from one used for the rabies vaccine. Treatment should not
be withheld while waiting tests or quarantined animals.
Intradermal
injection of vaccine for post rabies exposure is done in some developing
countries, which is much cheaper since less vaccine is given intradermally.
The vaccine is given at days 0, 3, and 7 in double doses; and at
days 28 and 90 at single doses. Some North American centres will
give intradermal injections for pre-exposure since this is likewise
cheaper. However when doing the intradermal method, these patients
have to be followed closely by lab tests to confirm the effectiveness
of this type of immunization with extra injections given if a low
immunoglobins titre is found.
Complied
by Gary Podolsky June 2001 Reference 1. Pasteur Merieux Connaught
monograph 2001 W.H.O- guidelines on rabies.
Japanese
Encephalitis Virus
This
is a mosquito acquired flavivirus infection that occurs in Asia.
At least 35,000 cases with 10,000 deaths are reported yearly. The
virus is similar to Yellow Fever and other flavivirus.
Most
infections are not symptomatic. One in 250 infections cause illness
after 5-15 days of incubation. Illness begins with a high fever,
changes in mental status, gastrointestinal symptoms, headache followed
by disturbances in speech, gait or motor problems. Symptoms progress
to stupor and coma. Five-30% of cases are fatal and 1/3 of survivors
may have neurological injury. Treatment of Japanese Encephalitis
is mostly supportive for affected people.
Japanese
Encephalitis Vaccine
Japanese
Encephalitis Vaccine is used to protect local populations in Asia
who are most at risk. Others, such as military personnel or expatriates
(people who live as residents during a transmission season) may
consider the vaccine. In most Asian countries the peak Japanese
Encephalitis season lasts about 5 months and traveler's need only
be vaccinated if at high risk during that time.
Risk
factors for traveler's included:
Travel to endemic country.
Travel during transmission season
Travel to rural areas (worse in rice paddies or near pig
farms)
Extended period of residence or travel >4wks.
Advanced age
Pregnancy (risk to developing fetus)
Protective
factors:
Repellants
Protective clothing
Residence in air-conditioned or well-screened areas
Permethrin mosquito nets
|
The
Japanese Encephalitis vaccine is given in 3 doses administered at
0,7, and at 14-21 days, with a booster at 3 years. Side effects
of vaccination include local redness and soreness at vaccination
site, low-grade fever, and muscle aches. Allergic reactions to JEV
have occurred up to 20-336 hours after vaccination, which are treatable
with corticosteroids and antihistamines.
In
conclusion, Japanese Encephalitis is extremely rare in travelers
but immunization may be indicated for select people.

Figure
9 World distribution of Japanese encephalitis
Risk
of Japanese Encephalitis By Country, Region, and Season |
Country
|
Affected
Area |
Transmission
Season |
Comments
|
Bangladesh
|
Few
data, probably widespread |
Possible
July-December as in northern India |
Outbreak
reported from Tangail district, Dacca division; sporadic cases
in Rajshahi division |
Bhutan
|
No
data |
No
data; presumed to be similar to Nepal presumed year-round
transmission |
Not
applicable |
Brunei
|
Presumed
to be sporadic-endemic as in Malaysia |
Presumed
year-round transmission |
Not
applicable |
Cambodia
|
Endemic-hyper
endemic countrywide |
Presumed
to be May-October |
Highly
prevalent in rural areas near Phnom Penh; some JE cases confirmed
in epidemics of uncertain etiology, Oct-Dec 1993-1998 |
Democratic
Republic of Korea |
Presumed
countrywide chiefly in rural areas <800m |
July-October
|
Epidemics
reported in the 1970's few recent data |
India
|
Reported
cases from all states except Arunachal, Dadra, Daman, Diu,
Gujarat, Himachal, Jammu, Kashmir, Lakshadweep, Meghalaya,
Nagar Haveli, Orissa, Punjab, Rajasthan and Sikkim |
South
India: May-Oct, Goa: Oct-Jan, Tamil Nadu: Aug-Dec, Karnataka:
second peak (April-June in Mandya district) Andrha Pradesh:
Sept-Dec, North India: July-Dec |
Outbreaks
in West Bengal, Bihar, Karnataka, Tamil Nadu, Andrha Pradesh,
Assam, Uttar Pradesh, Maharashtra Manipure, Kerala, and Goa
Urban cases reported (e.g. Lucknow) |
Indonesia
|
Kalimantan,
Bali, Nusa Tenggara, Sulawesi, Mollucas, and West Irian Java,
Lombok |
Probably
year-round risk; varies by island; peak risks associated with
rainfall, rice cultivation, and presence of pigs. Peak periods
of risk, Nov-Mar; June-July in some years |
Hyperendemic
in Bali. Sporadic cases recognized elsewhere. Vaccine not
recommended if travel is to only urban areas. |
Japan
|
Rare
sporadic cases on all islands, except Hokkaido |
Jun-Sep
except Ryukyu islands (Okinawa) Apr-Oct |
Vaccine
not routinely recommended for travel to Tokyo and other major
cities. Enzootic transmission without human cases observed
on Hokkaido. |
Laos
|
Presumed
to be endemic-hyperendemic countrywide |
Presumed
to be May-Oct |
No
data available |
Malaysia
|
Sporadic-endemic
in all states of Peninsula, Sarawak, and probably Sabah |
Nov-Jan
peak on peninsula |
Most
cases from Penang, Perak, Salangor, Johore, and Sarawak; differentiate
cases from Nipah encephalitis |
Myanmar
|
Presumed
to be endemic-hyperendemic countrywide |
Presumed
to be May-Oct |
Repeated
outbreaks in Shan State in Chiang Mai Valley |
Nepal
|
Hyperendemic
in southern lowlands (Terai). Sporadic cases in Kathmandu
Valley |
July-December
|
Vaccine
not routinely recommended for travelers visiting high-altitude
areas only |
Papua
New Guinea |
Sporadic
cases reported from D'entrecasteaux islands, Gulf, Milne Bay,
Shouth Highland, West Sepik, Western provinces |
Unknown
|
Vaccine
not routinely recommended |
People's
Republic Of China |
Cases
in all provinces except Xizang (Tibet), Xinjiang, Qinghai.
Hyperendemic in southern China; endemic-periodically epidemic
in temperate areas. Rare cases in Hong Kong. New territories.
|
Northern
China: May-Sept, Southern China: Apr-Oct, (Guangshi, Ynnan,
Gwangdong, and Southern Fujian, Szechuan, Guizhou, Hunan,
Jiangsi provinces) |
Vaccine
not routinely recommended for travelers to urban areas only,
including Hong Kong |
Pakistan
|
May
be transmitted in central deltas |
Presumed
to be Jun-Jan |
Cases
reported near Karachi Endemic areas overlap those for West
Nile virus. |
Philippines
|
Presumed
to be endemic on all islands |
Uncertain,
speculations based on locations and agroecosystems: West Luzon,
Mindoro, Negro Palowan: Apr-Nov; Elsewhere: year-round-greatest
risk: April-January |
Outbreaks
described in Nueva Ecija, Luzon, and in Manila |
Republic
of Korea |
Rare
sporadic cases |
July-October
|
Last
major outbreaks 1982-1983 |
Russia
|
Far
eastern maritime areas south of Khabarousk |
Peak
period Jul-Sep |
Sporadic
transmission; differentiate cases from RSSE |
Singapore
|
Rare
cases; last indigenous cases in 1992 |
Year-round
transmission no longer detected |
Vaccine
not routinely recommended |
Sri
Lanka |
Rare
cases; last indigenous cases in 1992 |
Oct-Jan;
secondary peak of enzootic transmission May-June |
Recent
outbreaks in central (Anuradhapura) and northwestern provinces
|
Taiwan
|
Endemic,
sporadic cases; island wide |
Apr-Oct,
June peak |
Cases
reported in and around Taipei |
Thailand
|
Hyperendemic
in north; sporadic-endemic in south |
May-October
|
Annual
outbreaks in Chiang Mai Valley; sporadic cases in Bangkok
suburbs |
Vietnam
|
Endemic
hyperendemic in all provinces |
May-October
|
Highest
rates in and near Hanoi |
Western
Pacific and Australia |
Discrete
epidemics reported on Guam, Saipan (Northern Mariana Islands)
Sporadic cases in the Torres Strait and Cape York, Australia
|
Uncertain,
possible September-January in the Pacific; February-April
in northern Australia |
Enzootic
Cycle may not be sustainable; epidemics may follow introductions
of the virus. Single Australian mainland case reported in
1998 |
Reference:
The Textbook of Travel Medicine and Health, Second Edition 2001
Herbert L. Dupont, M.D., Robert Steffen, M.D.
Required
Vaccines.
Most
immunizations are elective and patients may decline if they wish.
Only Yellow fever and Meningitis vaccines are still required by
some countries for entry. This information may change with epidemiology
and governments policy changes.
In
the past smallpox and cholera were also required. Small pox is considered
eradicated but has recently been discussed as a bioterrorist threat
but there is as yet no convincing evidence that this is true.
Cholera
has been and is sometimes demanded by Ugandan and Sudanese officials
although this is not officially required. The WHO does not recommend
cholera vaccine.
Yellow
Fever
Yellow
fever is a virus transmitted by daytime biting mosquitoes in Central
and South America and Africa. It has a high mortality rate and countries
fear its accidental importation by unvaccinated travellers.
Many
countries require proof of immunization with the Yellow Fever Vaccine
if travelers are arriving from countries that might have yellow
fever. Each country has its own list and some include all countries.
Travelers
may require proof of Yellow fever vaccination, especially
if going through multiple countries, purely for political purposes
Travelers
may also be recommended Yellow Fever vaccine due to the
actual risk of disease.
Sometimes
the recommendations and requirements are different. This can be
confusing and people may phone our clinic line for clarification.
This information is also available at www.travmed.com
or www.who.int
.
The
Yellow fever vaccine is considered safe for healthy people, but
some individuals who were immune compromised, ill or very old have
become very sick and a few have died from this vaccine.
The
risk of a serious adverse event is recognized as less than one in
several hundred thousand or less, and no serious adverse events
have occurred in Canada. Despite this, vaccination is still recommended
and is still required for entry into some countries. Only registered
clinics, as certified by Health Canada are able to give this immunization.
 
Figure
10 Yellow Fever Distributions in Africa and South America
Meningitis
Meningococcal
Meningitis is a bacteria transmitted by aerosol droplets. This illness
is rare in North America but outbreaks have occurred. (Usually of
type the 'C' serotype)
High
risk groups identified include
College
age Students living on and off campuses
Military
Recruits
Correctional
Institutions
These
are all groups that have young adults clustered together.
Some
American universities require meningitis immunization prior
to admission, although this is not consistent. For these people
meningitis vaccines that are conjugated and that protect against
meningitis type A are recommended, and give very long protection.
|
Two
conjugated meningitis vaccines are available in Canada that gives
very long protection against the type c disease.
Outside
of North America other types of meningitis exist and a
different vaccine is needed. Menomune gives protection against types
a, c, w-135, and y. This is a polysaccharide-based vaccine and is
only effective for about 3 yrs (different countries estimate between
2-5 years).
A
new product, conjugated meningitis vaccine is effective against
type a, c, w-135, and y has been licensed in the US in 2005 and
is expected to arrive in Canada next year will give much longer
protection (? lifelong). This immunization is not really needed
in North America but will have a huge public Health benefit in the
African countries that lie within the "meningitis belt"

Figure
11 Meningitis belt of Africa
|
Meningitis
Requirements and Recommendations for Travelers |
|
Meningitis
immunization with Menemune is recommended for travelers with
"extended contact" going to:
The
Sub-Saharan African "meningitis belt"
Other
countries including Nepal and Outer Mongolia but to a much
lesser degree.
This
list may change so please check with us regarding up to date
recommendations. |
Meningitis
Vaccination Is Required For All Travelers To Saudi Arabia
For Entry |
Malaria
Malaria
affects 500 million people worldwide and kills at least 2 million
per year. Over one million Africans die yearly (mostly children).
Yearly, 30,000 Europeans and North Americans are affected. Anopheles
mosquitoes are responsible. They carry malarial parasites, (plasmodium
falciparum, vivax, oval, or malaria), which are four different species.
Anopheles
mosquitoes are sometimes identifiable by the way they bite (head
downward when biting), compared with Culex mosquitoes that stand
parallel. Female mosquitoes of the Anopheles type bite at night
or twilight. Urbanization may create areas where mosquitoes may
breed close to people (stagnant water).
Mosquitoes
don't travel more than two miles from where they are bred. Weird
exceptions are airport malaria acquired by passengers being bitten
by mosquitoes indoors during stopovers. Wind could also blow mosquitoes
further away. Only female mosquitoes drain blood. Males eat nectars
and fluids.
Malaria
is caused by a parasite transmitted by certain species of mosquito.
Once a mosquito bites an infected person the parasite, a gamocyte
enters the mosquito and breeds internally creating oocytes and then
sporocites, which travel to the salivary glands of the mosquito.
These sporocites can penetrate the liver of an infected human within
45 minutes. Within 9-16 days the sporocites differentiate into merozites,
which invade red blood and liver cells. Blood cells rupture, releases
gametocytes and merozites, which cause the cycle of fevers and chills.
Different
malarial species cause different severity of diseases all of which
are bad. Sometimes malaria may be easy to recognize, but also sometimes
difficult to diagnose. Symptoms of malaria may be very subtle -
flu like attack, fever and chills which may lead to multi-organ
failure and death. It is important to note that malaria medication
will lessen symptoms of malaria but does not guarantee immunity.
Malaria chemoprophylaxis helps prevent life threatening malaria
that will kill people before they reach medical attention. Any symptoms
should be investigated with a thick and thin malarial smear. This
can still lead to misdiagnosis, as a smear may not "catch"
parasites on microscopic analysis. If malaria is suspected, one
normal smear does not rule it out. It is generally assumed that
any returning traveller with fever has malaria until proven otherwise.
Many other infectious diseases may also manifest with flu like symptoms
but malaria is the one diagnosis not to miss.
Many
other mosquitoes co-exist with the Anopheles mosquito-Aedes aegypti,
Culex, Haemogogus, Sabethes, and Masonia, which cause other diseases
like yellow fever, filariasis, viral encephalitis, dengue and other
hemorrhagic fevers. Other insects (tse-tse flies, black flies, deerflies,
sand flies, lice, ticks and mites) cause a variety of illnesses,
many of which have no known vaccine or medication to prevent illness
as well as no good treatment. General recommendations are to avoid
all insects similarly to malarial mosquitoes.
Prevention
is best accomplished by avoiding being bitten. Wear long sleeved
shirts and long pants. Use insect repellent, sleep under a mosquito
net, use mosquito coils, don't sleep on the ground, and check for
ticks and insect bites daily. Travelers should be knowledgeable
of the signs and symptoms of the diseases you may likely encounter
where you are travelling.
Types
of medication to prevent malaria (chemoprophylaxis) include:
Chloroquine:
(Aralen ): Cheap, well tolerated but bitter in taste, can cause
upset stomach and blurred vision. There are many areas resistant
to Chloroquine. Medication is started one week prior to travel,
and taken weekly during and for four weeks after trip.
Mefloquine:
(Larium): More expensive, but 2-5% of people reported side effects
(anxiety, nausea, hair loss, poor sleep, irritation). It is used
where Chloroquine resistance. Medication is also weekly, starting
one week before, during trip and for four weeks after the trip.
Doxycycline
: Daily medication used where there is mefloquine resistance or
as an alternative to above. Side effects include stomach irritation
and photosensitivity. It is started two days prior to the trip,
and continues for four weeks after leaving area.
Chloroquine,
mefloquine and doxycycline should be taken for 4 additional weeks
after leaving the malarious area because they are only effective
for malaria in the blood. Since the parasite may be in the liver
for 4 weeks, they must also be taken for that long. Long-term use
should be monitored for adverse effects but has been used for years
in expatriates.
Malarone:
(Atoraquine/Proquinil): Is new, but expensive and can cause nausea
and vomiting. This drug may be started 2 days before the trip. It
is taken daily and then discontinued 7 days after the trip. It is
discontinued sooner because it is effective at killing malaria in
the liver. So there is no need to take this medication as long as
mefloquine, Chloroquine or doxycycline.
Self-treat
malaria kits are available. Many travelers would do self-testing
and then treat themselves with strong anti-malarial. Large doses
of malaria drugs in a sick person are not without side effects.
Self-treatment is not recommended by our clinic since we feel that
many travelers will over treat themselves. Instead preventative
measures are best and one must seek medical attention immediately
if ill. Ninety percent of travelers with malaria do not become ill
until after they return home. This illusion of good health may foster
urban myths among travelers on laxity of mosquito precautions.
Taking
medications to prevent malaria is not a perfect solution but is
still the over all best way to prevent malaria. All the malaria
medications have some type of side effects but the benefits of them
preventing malaria far outweigh these effects.
Other
Travel Medicine Issues
Cruise
Ship Medicine
Travelers
embarking on Cruise vacations should also consider immunizations
for the countries visited in port as well as contact with crew and
other passengers
Travelers
going on cruises may have concerns about seasickness, risk of outbreaks
and other concerns, which may be addressed during their immunization
visit. This will be discussed in our Cruise ship session.
Scuba
Medicine
Scuba
concerns are also a frequent issue with travellers
Any
diver with an acute problem suggestive of a serious dive accident
must attend the nearest emergency centre for immediate treatment.
Our clinic is listed as a resource through the divers alert
network , and can be consulted on for dive injuries but
acute cases must always go through the emergency department.
Divers
Alert Network (DAN at www.diversalertnetwork.com
) is an excellent resource for divers with pre existing medical
problems as well as those with suspected Dive injuries. They have
a good travel insurance plan for divers and also provide phone assistance
for divers.
Aviation
Medicine
Our
clinic sees many people with anxieties and questions about flying.
Our session on in flight emergencies will discuss medical concerns
that may arise aboard aircrafts.
Jet
Lag
Jet
Lag is encountered as travelers cross time zones and is typically
worse going east. Various treatments and diets have been advocated.
There
is benefit to exercise in the morning on arrival and exposure to
bright light. Both benadryl and melatonin have been used (melatonin
is not licensed for use in Canada). Benzodiazepams and sedatives
should be avoided as they generally make sleep worse.
Conclusions
Travel
Medicine remains an interesting new discipline. There are many references
available to assist family physicians in developing their own travel
services for patients. Specialized or exotic travels may require
referral to specialized travel clinics.
References:
Travel
Medicine and Migrant Health.
International
Society Travel Medicine, General Meeting, 2001
Baxter
monograph on Tick Borne Encephalitis
International
Travel Health Guide 2001 - Twelfth Edition: Stuart Rose, M.D.
Textbook
of Travel Medicine and Health- Second Edition: Herbert L. Dupont,
M.D., Robert Steffen, M.D.
Canada
Communicable Disease Report Volume 27, No.15 - August 1, 2001
Key
Travel Health Information Sites for Canadians
World
Health Organization http://www.who.int
International
Travel and Health: Vaccination Requirements and Health Advice, January
2000 edition www.who.int/it.english.index.htm
Detailed
country by country yellow fever vaccination and malaria requirements
Disease
Outbreak News - http://www.who.int.emc/outbreak_news/index.html
Listings of current
outbreaks, along with archives dating back to 1996
International
Immunization Profiles - http://www.who.int/gpv-surv/intro.html
Listing of international
immunization profiles and schedules from the Global Programme for
Vaccines and Immunization.
Centers
for Disease Control and Prevention http://www.cdc.gov/travel/index.html
Includes
information on disease outbreaks around the world, geographic health
recommendations, and information on specific diseases.
Health
Information for International Travel (Yellow Book) - http:/www.cdc.gov/travel/reference.htm
complete text of the 19999-2000 editions available electronically
at the above URL.
Includes
in-depth information on: vaccination and disease prevention; yellow
fever vaccine requirements and malaria risk and prophylaxis by country;
and information for travelers with special needs
The
Blue Sheet - www.cdc.gov/travel.bluesheet.htm
Summary
of Health Information for International Travel " Lists cholera,
yellow fever, and plague infected countries.
Morbidity
and Morality Weekly Report - http://www2.cdc.gov/mmwr/mmwr_wk.html
Weekly CDC publication
containing information useful for travel health practitioners
International
Society of Travel Medicine http://www.istm.org/
Listings
of travel clinics in over 50 countries around the world
|